click below
click below
Normal Size Small Size show me how
Parkinson / Ner Sys
ch 17, therapeutic agents for the nervous system - pharm tech
| Question | Answer |
|---|---|
| Parkinson disease | progressive disorder associated with the loss or deficiency of dopamine, a neurotransmitter |
| TRAP symptoms | tremor, rigidity, akinesia (for bradykinesia), and postural instability |
| Sinemet | levodopa / carbidopa *levodopa / carbidopa class |
| Mirapex | pramipexole *dopamine agonist |
| Requip | ropinirole *dopamine agonist |
| Neupro | rotigotine *dopamine agonist |
| Cogentin | benztropine *anticholinergic |
| Artane | trihexyphenidyl *anticholinergic |
| Symmetrel | amantadine *anticholinergic |
| Catechol-O-Methyltransferase inhibitors | COMT inhibitors; prevent the peripheral conversion of levodopa by the enzyme COMT |
| Comtan | entacapone *COMT inhibitor |
| Tasmar | tolcapone *COMT inhibitor |
| Monoamine Oxidase-B Inhibitors | MAO-B Inhibitors; inhibition of MAO-B decreases the metabolism of dopamine in the CNS |
| Azilect | rasagiline *MAO-B Inhibitors |
| Eldepryl or Zelapar | selegiline *MAO-B Inhibitors |
| 5 classes of PD medications | levodopa/carbidopa, dopamine agonists, anticholinergics, COMT inhibitors, and MAO-B inhibitors |